Skip to main content
SpringerLink
Log in

Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

  • Book
  • © 2012

Overview

Editors:
  1. Jianguo Tao

    1. Research Institute, Department of Hematopathology and, H. Lee Moffitt Cancer Center &, Tampa, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Eduardo Sotomayor

    1. Research Institute, Department of Malignant Hematology, H. Lee Moffitt Cancer Center &, Tampa, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Compiles new knowledge on pathobiology of hematologic cancer
  • Gives comprehensive information on current treatments on malignant hematologic diseases
  • Written by international leaders on the field

Part of the book series: Cancer Growth and Progression (CAGP, volume 14)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Front Matter

    Pages i-vi
    Download chapter PDF

  2. B Cell Growth, Differentiation and Malignancies

    • Jianguo Tao, Chih-Chi Andrew Hu
    Pages 1-20

  3. Follicular Lymphoma: Recent Advances

    • Alyssa Bouska, SharathKumar Bagvati, Javeed Iqbal, Basem M. William, Wing C. Chan
    Pages 21-42

  4. Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy

    • Javier Pinilla-Ibarz, Chih-Chi Andrew Hu
    Pages 43-52

  5. Genetic and Environmental Determinants in Multiple Myeloma: Implications for Therapy

    • Kenneth H. Shain, William S. Dalton
    Pages 53-82

  6. EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly

    • Jorge J. Castillo
    Pages 83-98

  7. HIV and Lymphoma

    • Lubomir Sokol, Brady E. Betran
    Pages 99-111

  8. Molecular Biology of Mantle Cell Lymphoma

    • Bijal Shah, Peter Martin, Jianguo Tao, Eduardo M. Sotomayor
    Pages 113-135

  9. Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disorders

    • Ling Zhang, Jianguo Tao
    Pages 137-156

  10. Pathogenesis of Non-Hodgkin Lymphoma Derived from Infection Diseases

    • Ling Zhang, Roger Klein
    Pages 157-180

  11. Hodgkin Lymphoma: From Molecular Pathogenesis to Targeted Therapy

    • Ádám Jóna, Árpád Illés, Anas Younes
    Pages 181-202

  12. Myelodysplastic Syndromes

    • Grant E. Nybakken, Adam Bagg
    Pages 203-240

  13. Chronic Myeloproliferative Disorders:From Molecular Pathogenesis to Targeted Therapy

    • Richard A. Walgren, Josef Prchal
    Pages 241-276

  14. Chronic Myeloid Leukemia

    • Kapil Bhalla, Celalettin Ustun, Warren Fiskus
    Pages 277-314

  15. Novel Targeted Therapeutics for Acute Myeloid Leukemia

    • Vu Duong, Jeffrey Lancet
    Pages 315-348

  16. Novel Targeted Therapeutics for Peripheral T-Cell Lymphoma

    • Owen O. Connor, Salvia Jain, Jasmine Zain
    Pages 349-372

  17. Large Granular Lymphocyte Leukemia – From Molecular Pathogenesis to Targeted Therapy

    • Mithun Vinod Shah, Thomas P. Loughran Jr.
    Pages 373-393

  18. Epigenetic Regulation and Therapy in Lymphoid Malignancies

    • Yizhuo Zhang, Shanqi Guo, Haifeng Zhao
    Pages 395-418

  19. Back Matter

    Pages 419-426
    Download chapter PDF
Back to top

Keywords

About this book

In the last decade, there has been a remarkable explosion of knowledge in hematologic cancer from basic molecular biology and pathology to clinical therapy. This has led to many new advance and insights in the understanding of pathobiology of malignant hematology. New knowledge of disease molecular pathology, cytogenetic, epigenetic and genomic alterations have provided new strategies to attack and eradicate tumor cells at molecular level and significantly impacted our current therapeutics for hematological malignancies. The recent and ongoing rapid expansion of knowledge in this area has become extensive, dynamic and diffuse over the literature and research publications. This has led to the need to capture and compile the new and current information about hematologic cancer with special emphasis on translation from molecular pathobiology to targeted therapeutics. In this book experts from around the world share their thoughts and knowledge about the pathobiology of hematologic cancer,as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology physicians, hematopathologist as well as basic research scientist in the area of hematologic malignancies.

Editors and Affiliations

  • Research Institute, Department of Hematopathology and, H. Lee Moffitt Cancer Center &, Tampa, USA

    Jianguo Tao

  • Research Institute, Department of Malignant Hematology, H. Lee Moffitt Cancer Center &, Tampa, USA

    Eduardo Sotomayor

Bibliographic Information

  • Book Title: Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics

  • Editors: Jianguo Tao, Eduardo Sotomayor

  • Series Title: Cancer Growth and Progression

  • DOI: https://doi.org/10.1007/978-94-007-5028-9

  • Publisher: Springer Dordrecht

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Science+Business Media Dordrecht 2012

  • Hardcover ISBN: 978-94-007-5027-2Published: 13 November 2012

  • Softcover ISBN: 978-94-007-9581-5Published: 14 December 2014

  • eBook ISBN: 978-94-007-5028-9Published: 13 November 2012

  • Series ISSN: 1871-3238

  • Edition Number: 1

  • Number of Pages: VI, 426

  • Topics: Cancer Research, Hematology, Laboratory Medicine, Molecular Medicine, Apoptosis, Cell Biology

Publish with us

Policies and ethics

Back to top

Search

Navigation